These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1673 related articles for article (PubMed ID: 20442654)

  • 1. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
    Galach M; Utikal J
    Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.
    Parameswaran S; Balasubramanian S; Rao MS; Ahmad I
    Stem Cells; 2011 Jul; 29(7):1013-20. PubMed ID: 21544901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and genetic modification of induced pluripotent stem cells.
    Schambach A; Cantz T; Baum C; Cathomen T
    Expert Opin Biol Ther; 2010 Jul; 10(7):1089-103. PubMed ID: 20528610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of induced pluripotent stem cells from somatic cells.
    Sohn YD; Han JW; Yoon YS
    Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
    Anastasia L; Pelissero G; Venerando B; Tettamanti G
    Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches for the generation of induced pluripotent stem cells.
    Sidhu KS
    Expert Opin Biol Ther; 2011 May; 11(5):569-79. PubMed ID: 21314494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.
    Hasegawa K; Zhang P; Wei Z; Pomeroy JE; Lu W; Pera MF
    Stem Cells; 2010 Aug; 28(8):1338-48. PubMed ID: 20572011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
    Das AK; Pal R
    J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An overview of pluripotent stem cell lines].
    Kieffer E; Kuntz S; Viville S
    Med Sci (Paris); 2010 Oct; 26(10):848-54. PubMed ID: 20929676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage.
    Li F; Bronson S; Niyibizi C
    J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
    Hussein SM; Nagy AA
    Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
    Jozefczuk J; Prigione A; Chavez L; Adjaye J
    Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different developmental potential of pluripotent stem cells generated by different reprogramming strategies.
    Jiang J; Ding G; Lin J; Zhang M; Shi L; Lv W; Yang H; Xiao H; Pei G; Li Y; Wu J; Li J
    J Mol Cell Biol; 2011 Jun; 3(3):197-9. PubMed ID: 21624975
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of chromatin modifying factors' gene expression in embryonic and induced pluripotent stem cells.
    Luzzani C; Solari C; Losino N; Ariel W; Romorini L; Bluguermann C; Sevlever G; Barañao L; Miriuka S; Guberman A
    Biochem Biophys Res Commun; 2011 Jul; 410(4):816-22. PubMed ID: 21703227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprogramming adult hematopoietic cells.
    Kaneko S; Otsu M; Nakauchi H
    Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can controlled cellular reprogramming be achieved using microRNAs?
    Sun X; Fu X; Han W; Zhao Y; Liu H
    Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
    Kang L; Kou Z; Zhang Y; Gao S
    J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.